BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23800614)

  • 1. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects.
    Muguruza C; Lehtonen M; Aaltonen N; Morentin B; Meana JJ; Callado LF
    Schizophr Res; 2013 Aug; 148(1-3):145-50. PubMed ID: 23800614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches.
    Aydin E; Cebo M; Mielnik J; Richter H; Schüle R; Sievers-Engler A; Młynarz P; Lämmerhofer M
    J Pharm Biomed Anal; 2023 Jan; 222():115090. PubMed ID: 36252552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troubleshooting in LC-MS/MS method for determining endocannabinoid and endocannabinoid-like molecules in rat brain structures applied to assessing the brain endocannabinoid/endovanilloid system significance.
    Bystrowska B; Smaga I; Tyszka-Czochara M; Filip M
    Toxicol Mech Methods; 2014 May; 24(4):315-22. PubMed ID: 24576199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of brain endocannabinoid levels by voluntary alcohol consumption in alcohol-preferring AA rats.
    Malinen H; Lehtonen M; Hyytiä P
    Alcohol Clin Exp Res; 2009 Oct; 33(10):1711-20. PubMed ID: 19572983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner.
    Ramírez-López MT; Vázquez M; Lomazzo E; Hofmann C; Blanco RN; Alén F; Antón M; Decara J; Arco R; Orio L; Suárez J; Lutz B; Gómez de Heras R; Bindila L; Rodríguez de Fonseca F
    PLoS One; 2017; 12(3):e0174307. PubMed ID: 28346523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower circulating endocannabinoid levels in children with autism spectrum disorder.
    Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J
    Mol Autism; 2019; 10():2. PubMed ID: 30728928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraction and Simultaneous Quantification of Endocannabinoids and Endocannabinoid-Like Lipids in Biological Tissues.
    Bindila L; Lutz B
    Methods Mol Biol; 2016; 1412():9-18. PubMed ID: 27245887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain.
    Palkovits M; Harvey-White J; Liu J; Kovacs ZS; Bobest M; Lovas G; Bagó AG; Kunos G
    Neuroscience; 2008 Apr; 152(4):1032-9. PubMed ID: 18343585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease.
    Bisogno T; Martire A; Petrosino S; Popoli P; Di Marzo V
    Neurochem Int; 2008 Jan; 52(1-2):307-13. PubMed ID: 17664017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endocannabinoids and cannabimimetic fatty acid derivatives are altered in gastroparesis: A sex- and subtype-dependent observation.
    Bashashati M; Leishman E; Bradshaw H; Sigaroodi S; Tatro E; Bright T; McCallum R; Sarosiek I
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13961. PubMed ID: 32779297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraction and Simultaneous Quantification of Endocannabinoids and Endocannabinoid-Like Lipids in Biological Tissues.
    Schwitter C; Lutz B; Bindila L
    Methods Mol Biol; 2023; 2576():9-19. PubMed ID: 36152174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry.
    Balvers MG; Verhoeckx KC; Witkamp RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1583-90. PubMed ID: 19395322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
    Pantazopoulos H; Stone D; Walsh J; Benes FM
    Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.
    Leweke FM; Giuffrida A; Koethe D; Schreiber D; Nolden BM; Kranaster L; Neatby MA; Schneider M; Gerth CW; Hellmich M; Klosterkötter J; Piomelli D
    Schizophr Res; 2007 Aug; 94(1-3):29-36. PubMed ID: 17566707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous cannabinoids in post-mortem brains of Cloninger type 1 and 2 alcoholics.
    Lehtonen M; Storvik M; Tupala E; Hyytiä P; Tiihonen J; Callaway JC
    Eur Neuropsychopharmacol; 2010 Apr; 20(4):245-52. PubMed ID: 20122818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline.
    Altamura C; Ventriglia M; Martini MG; Montesano D; Errante Y; Piscitelli F; Scrascia F; Quattrocchi C; Palazzo P; Seccia S; Vernieri F; Di Marzo V
    J Alzheimers Dis; 2015; 46(2):497-506. PubMed ID: 25818503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Endocannabinoids in Canine Multicentric Lymphoma Patients.
    Hay JK; Hocker SE; Monteith G; Woods JP
    Front Vet Sci; 2022; 9():828095. PubMed ID: 35242839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia.
    Clarke DJ; Stuart J; McGregor IS; Arnold JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():9-15. PubMed ID: 27521758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.